Lactobacillus Farciminis and Hyperalgesia

Lallemand SAS48 enrolled

Overview

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Inflammation Pain

Interventions

Lactobacillus farciminisDRUG

1 capsule per day. Each capsule containing 4\*109 CFU

PlaceboDRUG

1 capsule per day

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * healthy volunteers Exclusion Criteria: * consumption of yogurts

Locations (1)

Cpc / Cic-Inserm 501

Clermont-Ferrand, France

Outcomes

Primary Outcomes

Measurement of the mchanical pain threshold in primary and secondary areas by using a punctate stimulus.

Secondary Outcomes

Measurement of cutaneous temperature of hyperalgesia areas

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.